Microarrays in Parkinson's Disease: A Systematic Approach

NeuroRx

Volumn 3, Issue 3, 2006, Pages 319-326

  Miller, Renee M ^a   Federoff, Howard J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

synuclein; gene expression; human; Microarray; MPTP; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BIOLOGICAL MARKER; TOXIN;

ARTICLE; BIOLOGY; CLINICAL FEATURE; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE MARKER; DISEASE MODEL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC MODEL; GENETIC SUSCEPTIBILITY; HUMAN; IDIOPATHIC DISEASE; MICROARRAY ANALYSIS; NONHUMAN; PARKINSON DISEASE; RODENT; SAMPLE; STATISTICAL ANALYSIS; SYSTEMS BIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; MICROARRAY ANALYSIS; PARKINSON DISEASE;

EID: 33745354666     PISSN: 15455343     EISSN: 15455351     Source Type: Journal    
DOI: 10.1016/j.nurx.2006.05.008     Document Type: Article

References (40)

1. Maguire-Zeiss K.A., and Federoff H.J. Convergent pathobiologic model of Parkinson's disease. Ann NY Acad Sci 991 (2003) 152-166
2. Bezard E., Gross C.E., Fournier M.C., Dovero S., Bloch B., and Jaber M. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Exp Neurol 155 (1999) 268-273
3. Gainetdinov R.R., Fumagalli F., Jones S.R., and Caron M.G. Dopamine transporter is required for in vivo MPTP neurotoxicity. evidence from mice lacking the transporter. J Neurochem 69 (1997) 1322-1325
4. Gainetdinov R.R., Fumagalli F., Wang Y.M., Jones S.R., Levey A.I., Miller G.W., et al. Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice. J Neurochem 70 (1998) 1973-1978
5. Teismann P., Tieu K., Cohen O., Choi D.K., Wu du C., Marks D., et al. Pathogenic role of glial cells in Parkinson's disease. Mov Disord 18 (2003) 121-129
6. Perez F.A., Curtis W.R., and Palmiter R.D. Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity. BMC Neurosci 6 (2005) 71
7. Fornai F., Schluter O.M., Lenzi P., Gesi M., Ruffoli R., Ferrucci M., et al. Parkinson-like syndrome induced by continuous MPTP infusion. convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102 (2005) 3413-3418
8. Galvin J.E., Lee V.M., and Trojanowski J.Q. Synucleinopathies. clinical and pathological implications. Arch Neurol 58 (2001) 186-190
9. Fleming S.M., Fernagut P.O., and Chesselet M.F. Genetic mouse models of parkinsonism. strengths and limitations. NeuroRx 2 (2005) 495-503
10. Bove J., Prou D., Perier C., and Przedborski S. Toxin-induced models of Parkinson's disease. NeuroRx 2 (2005) 484-494
11. Ginsberg S.D., Che S., Counts S.E., and Mufson E.J. Single cell gene expression profiling in Alzheimer's disease. NeuroRx 3 (2006) 302-317
12. Olson N.E. The microarray data analysis process. from raw data to biological significance. NeuroRx 3 (2006) 371-381
13. Almudevar A., Klebanov L.B., Qiu X., Salzman P., and Yakovlev A.Y. Utility of correlation measures in analysis of gene expression. NeuroRx 3 (2006) 382-393
14. Fathallah-Shaykh H.M. Microarrays. applications and pitfalls. Arch Neurol 62 (2005) 1669-1672
15. Blalock E.M., Chen K.C., Stromberg A.J., Norris C.M., Kadish I., Kraner S.D., et al. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease. statistical reliability and functional correlation. Aging Res Rev 4 (2005) 481-512
16. Colangelo V., Schurr J., Ball M.J., Pelaez R.P., Bazan N.G., and Lukiw W.J. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1. transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70 (2002) 462-473
17. Loring J.F., Wen X., Lee J.M., Seilhamer J., and Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol 20 (2001) 683-695
18. Dangond F., Hwang D., Camelo S., Pasinelli P., Frosch M.P., Stephanopoulos G., et al. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol Genomics 16 (2004) 229-239
19. Jiang Y.M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 57 (2005) 236-251
20. Chan E.Y., Luthi-Carter R., Strand A., Solano S.M., Hanson S.A., DeJohn M.M., et al. Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. Hum Mol Genet 11 (2002) 1939-1951
21. Borovecki F., Lovrecic L., Zhou J., Jeong H., Then F., Rosas H.D., et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci USA 102 (2005) 11023-11028
22. Strand A.D., Aragaki A.K., Shaw D., Bird T., Holton J., Turner C., et al. Gene expression in Huntington's disease skeletal muscle. a potential biomarker. Hum Mol Genet 14 (2005) 1863-1876
23. Grunblatt E., Mandel S., Maor G., and Youdim M.B. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray. effect of R-apomorphine. J Neurochem 78 (2001) 1-12
24. Miller R.M., Callahan L.M., Casaceli C., Chen L., Kiser G.L., Chui B., et al. Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra. J Neurosci 24 (2004) 7445-7454
25. Miller R.M., Chen L.L., Kiser G.L., Giesler T.L., Kaysser-Kranich T.M., Palaniappan C., et al. Temporal evolution of mouse striatal gene expression following MPTP injury. Neurobiol Aging 26 (2005) 765-775
26. Napolitano M., Centonze D., Calce A., Picconi B., Spiezia S., Gulino A., et al. Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum. Neurobiol Dis 10 (2002) 387-395
27. Schwarting R.K., and Huston J.P. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 49 (1996) 215-266
28. Schultz W. Depletion of dopamine in the striatum as an experimental model of Parkinsonism. direct effects and adaptive mechanisms. Prog Neurobiol 18 (1982) 121-166
29. Holtz W.A., and O'Malley K.L. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem 278 (2003) 19367-19377
30. Yoo M.S., Chun H.S., Son J.J., DeGiorgio L.A., Kim D.J., Peng C., et al. Oxidative stress regulated genes in nigral dopaminergic neuronal cells. correlation with the known pathology in Parkinson's disease. Brain Res Mol Brain Res 110 (2003) 76-84
31. Chun H.S., Gibson G.E., DeGiorgio L.A., Zhang H., Kidd V.J., and Son J.H. Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism. J Neurochem 76 (2001) 1010-1021
32. Scherzer C.R., Jensen R.V., Gullans S.R., and Feany M.B. Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease. Hum Mol Genet 12 (2003) 2457-2466
33. Hauser M.A., Li Y.J., Xu H., Noureddine M.A., Shao Y.S., Gullans S.R., et al. Expression profiling of substantia nigra in Parkinson's disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Arch Neurol 62 (2005) 917-921
34. Grunblatt E., Mandel S., Jacob-Hirsch J., Zeligson S., Amariglo N., Rechavi G., et al. Gene expression profiling of parkinsonian substantia nigra pars compacta. alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 111 (2004) 1543-1573
35. Miller R.M., Kiser G.L., Kaysser-Kranich T.M., Lockner R.J., Palaniappan C., and Federoff H.J. Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease. Neurobiol Dis 21 (2006) 305-313
36. Miller R.M., and Federoff H.J. Altered gene expression profiles reveal similarities and differences between Parkinson's disease and model systems. Neuroscientist 11 (2005) 539-549
37. Erlanson-Albertsson C. Uncoupling proteins. a new family of proteins with unknown function. Nutr Neurosci 5 (2002) 1-11
38. Ermak G., Cheadle C., Becker K.G., Harris C.D., and Davies K.J. DSCR1(Adapt78) modulates expression of SOD1. FASEB J 18 (2004) 62-69
39. Simon H.H., Saueressig H., Wurst W., Goulding M.D., and O'Leary D.D. Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J Neurosci 21 (2001) 3126-3134
40. Simon H.H., Bhatt L., Gherbassi D., Sgado P., and Alberi L. Midbrain dopaminergic neurons. determination of their developmental fate by transcription factors. Ann NY Acad Sci 991 (2003) 36-47